Industry Update: Interim 503A and 503B Bulks Lists New Revisions US$ 25.39 Min. order: 1 piece ★★★★★ 4.4 (131 reviews) Sold : Login>>
This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides US$ 27.91 Min. order: 1 piece ★★★★★ 4.7 (210 reviews) Sold : Login>>
FDA May Reverse Ban on 14 Peptides—What It Means for Your Beauty Routine US$ 28.00 Min. order: 1 piece ★★★★★ 4.6 (94 reviews) Sold : Login>>
BPC-157 has a decades-long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with US$ 27.02 Min. order: 1 piece ★★★★★ 4.6 (215 reviews) Sold : Login>>
Understanding the Legal Risks of BPC-157 and Other Unapproved Peptides – Holt Law US$ 24.14 Min. order: 1 piece ★★★★★ 4.8 (225 reviews) Sold : Login>>
Regulatory Alert: FDA's April 2026 Update on BPC-157 and GHK-Cu – Holt Law US$ 27.45 Min. order: 1 piece ★★★★★ 4.6 (152 reviews) Sold : Login>>